Anna N. A. Tosteson, ScD
Title(s):
Professor of Medicine
Professor of Community and Family Medicine
Interim Director and Professor of The Dartmouth Institute
James J. Carroll 1948 Professor of Oncology
Additional Titles/Positions/Affiliations:
Director, Comparative Effectiveness Research Program, The Dartmouth Institute for Health Policy and Clinical Practice
Associate Director for Population Sciences, Norris Cotton Cancer Center
Associate Director, SYNERGY, Dartmouth's Clinical and Translational Science Institute
Department(s):
Medicine
Community and Family Medicine
The Dartmouth Institute
Education:
Biostatistics (Health Decision Sciences), Harvard University, ScD
Biostatistics, Harvard University, MS
Statistics & Biometry, Cornell University, BS
Programs:
Norris Cotton Cancer Center
SYNERGY
The Dartmouth Institute for Health Policy and Clinical Practice
Contact Information:
Dartmouth Medical School
HB 7505
One Medical Center Drive
Lebanon NH 03756
Office: WTRB 526, DHMC
Phone: 603-653-3568
Email: Anna.Tosteson@dartmouth.edu
Assistant: Christopher Jacobs
Asst. Phone: 603-653-0802
Asst. Email: Christopher.R.Jacobs@Dartmouth.EDU
Professional Interests:
Dr. Anna Tosteson is a decision scientist and health services researcher who studies how the diffusion of innovations in health care are changing health, costs and quality of care. Through study of diverse data sources including registries, clinical and epidemiological studies, and administrative claims data, she seeks insights into the long-term clinical and economic effects of alternative approaches to health care delivery with a focus on cancer screening, musculoskeletal disease, and women’s health.
Grant Information:
Promoting follow-up of abnormal cancer screening tests using population-based systems to support stepped care multilevel intervention. (NCI: U01CA225451 )
Risk-based breast cancer screening and surveillance in community practice. (NCI, P01CA154292)
Courses Taught:
PH 119/121; QBS 140 Decision and Cost-Effectiveness Analysis
Selected Publications: |
|
What matters most: Randomized controlled trial of breast cancer surgery conversation aids across socioeconomic strata. Integration of Registries with EHRs to Accelerate Generation of Real-World Evidence for Clinical Practice and Learning Health Systems Research: Recommendations from a Workshop on Registry Best Practices. The Development of a Crosswalk for Functional Measures in Postacute Medicare Claims. Screening Performance of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice by Patient Age, Screening Round, and Breast Density. Assessment of Radiologist Performance in Breast Cancer Screening Using Digital Breast Tomosynthesis vs Digital Mammography. Opportunities and Challenges of Claims-Based Quality Assessment: The Case of Postdischarge β-Blocker Treatment in Patients With Heart Failure With Reduced Ejection Fraction. Breast cancer risk, worry, and anxiety: Effect on patient perceptions of false-positive screening results. An Abbreviated MRI Protocol for Breast Cancer Screening in Women With Dense Breasts: Promising Results, but Further Evaluation Required Prior to Widespread Implementation. Knowledge and Perception of Breast Density, Screening Mammography, and Supplemental Screening: in Search of "Informed". Assessment of Second-Opinion Strategies for Diagnoses of Cutaneous Melanocytic Lesions. |